US Patent Issued to The Regents of the University of California, Northwestern University on May 13 for "Compositions and methods for enhancing adoptive T cell therapeutics" (California, Illinois Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,971, issued on May 13, was assigned to The Regents of the University of California (Oakland, Calif.) and Northwestern University (Evanston, Ill.).

"Compositions and methods for enhancing adoptive T cell therapeutics" was invented by Kole Roybal (San Francisco), Julie Garcia (San Francisco), Iowis Zhu (San Francisco), Jaehyuk Choi (Chicago) and Jay Daniels (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to compositions and methods for improving T cell therapy. In particular, the disclosure provides polypeptides and recombinant nucleic acid constructs and/or recombinant nucleic acids encoding polypeptid...